Development and characterization of a patient‑derived orthotopic xenograft of therapy‑resistant breast cancer.

导出 OA

翻译打印收藏纠错

第一作者： Ramesh,Butti

第一单位： Laboratory of Tumor Biology, Angiogenesis and Nanomedicine Research, National Centre for Cell Science, Pune, Maharashtra 411007, India.

作者： Ramesh,Butti ^[1] ; Prachi,Kapse ^[1] ; Garima,Bhadauriya ^[1] ; Suhail,Ahmad ^[2] ; Rohan,Chaubal ^[3] ; Pallavi,Parab ^[3] ; Rasika,Kadam ^[4] ; Soumya S,Mahapatra ^[5] ; Tanuja,Shet ^[3] ; Amit,Dutt ^[2] ; Sudeep,Gupta ^[3] ; Gopal C,Kundu ^[1]

作者单位： Laboratory of Tumor Biology, Angiogenesis and Nanomedicine Research, National Centre for Cell Science, Pune, Maharashtra 411007, India. ^[1] Integrated Cancer Genomics Laboratory, Tata Memorial Centre‑Advanced Centre for Treatment, Research and Education in Cancer (TMC‑ACTREC), Navi Mumbai, Maharashtra 410210, India. ^[2] Homi Bhabha National Institute, Training School Complex, Mumbai 400094, India. ^[3] Clinical Genomics and Hypoxia Lab (Clinician Scientist Lab), TMC‑ACTREC, Navi Mumbai, Maharashtra 410210, India. ^[4] School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University, Bhubaneswar, Odisha 751024, India. ^[5]

关键词 HER2 biomarker breast cancer estrogen receptor?α patient?derived orthotopic xenograft progesterone receptor?α